Atlas Trials

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Clinical trial NCT00303745 · UNKNOWN

Trial details

NCT number
NCT00303745
Sponsor
Federation Francophone de Cancerologie Digestive
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2006-06-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.